5-HT2 antagonist (antihistamine)
Pizotifen
Brand names: Sanomigran
Adult dose
Dose: Initial 500 micrograms ON, increase to 1.5mg ON (max 4.5mg/day in divided doses)
Route: PO
Frequency: ON
Clinical pearls
- Migraine prophylaxis (3rd-line; superseded by topiramate, propranolol, candesartan)
- Weight gain often limits use
Contraindications
- Closed-angle glaucoma
- Urinary retention
Side effects
- Drowsiness
- Weight gain
- Increased appetite
- Anticholinergic effects
Interactions
- CNS depressants
- MAOIs
Monitoring
- Weight
- Symptoms
Reference: BNF; NICE CG150; https://bnf.nice.org.uk/drugs/pizotifen/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS